R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

The ALS clinical trial landscape is characterised by a significant number of active trials and sponsors, including MediciNova's Ph3 with MN-166.

R&D

Cell and gene therapies are changing the way pharmaceutical organisations think about sample storage.

R&D

In June/July, companies continued to reshape their leadership teams in preparation for upcoming clinical, regulatory, and commercial milestones.

R&D

GLP-1 RA medicine has transformed treatment of metabolic diseases such as obesity and diabetes. We spoke with China's CORXEL about theirs.

R&D

May and June delivered a plethora of clinical trial updates. In the build-up to ASCO in June, our inbox was overflowing with oncology trial results.

R&D

Should traditional safety considerations be treated as distinct from broader ESG frameworks, or fully integrated within them?